Intractable Pain
1
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Flowonix MedicalNJ - Hackettstown
2 programsInfusion PumpN/A1 trial
Prometra Programmable PumpN/A1 trial
Active Trials
NCT00866164Approved For Marketing
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Sorrento TherapeuticsIntrathecal Resiniferatoxin
Flowonix MedicalInfusion Pump
Clinical Trials (3)
Total enrollment: 146 patients across 3 trials
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
Start: Aug 2009Est. completion: Jul 202636 patients
Phase 1Completed
Prometra's Utilization in Mitigating Pain II
N/AApproved For Marketing
Prometra's Utilization in Mitigating Pain (PUMP)
Start: Jan 2007Est. completion: Mar 2011110 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.